2008), Medicago sativa (Sourrouille et al., 2008) and Oryza sativa (Shin et al ... Plant systems are already being used for the production of biopharmaceuticals. β-Glucocerebrosidase, an enzyme for ...

Department of Chemical Engineering and Analytical Chemistry, Institute for Research on Nutrition and Food Safety (INSA·UB), University of Barcelona, 08028 Barcelona, Spain ...

Below is a curated list of the most popular sativa and sativa-dominant strains of 2024. The strains’ popularity was determined by a combination of factors, including data from state regulatory ...

revealing that enzyme effect is related to the diet composition. Therefore, it could be concluded that Nigella sativa meal can replace all soybean meal and can be included at 50 and 44% in starter and ...

Medicago, a Canadian biopharmaceutical company with manufacturing operations in Durham, is reporting positive results from a Phase 3 clinical trial of its potential COVID-19 vaccine made in plants.

Phosphorus (P) is the second most important nutrient after nitrogen (N) and can greatly diminish plant productivity if P supply is not adequate. Plants respond to soil P availability by adjusting root ...

Medicago and Mitsubishi this morning announced that Japan-based Mitsubishi Tanabe Pharma will acquire the Canadian vaccine company for $357 million. Medicago operates a facility in Research Triangle ...